Literature DB >> 8782874

Differential responses of oxytocin and vasopressin neurons to the osmotic and stressful components of hypertonic saline injections: a Fos protein double labeling study.

J J Xiong1, G I Hatton.   

Abstract

Expression of Fos protein, detected immunocytochemically, was used to assess the relative responses of supraoptic nucleus (SON) oxytocin- (OX) and vasopressin- (VP) containing neurons to the osmotic vs. the osmotic plus stressful components of intraperitoneal hypertonic saline injections. The percentage of SON neurons showing Fos-like immunoreactivity (Fos-ir) was quantified for rats receiving general anesthesia only, anesthesia 1 h prior to either isotonic or hypertonic saline injection or no anesthesia prior to hypertonic injection. Hypertonic saline injection with and without anesthesia induced Fos-ir in 66% and 77% of SON neurons, respectively, whereas isotonic saline with anesthesia and anesthesia alone resulted in 15% and 13%, respectively, of cells showing Fos-ir. Double labeling for Fos-ir and either OX-ir or VP-ir resulted in quantitatively different responses to hypertonic injections with and without anesthesia in OX-ir and VP-ir neurons. The VP-ir neuronal response was similar under the two conditions: 49% and 48% of VP cells displaying Fos-ir with and without prior anesthesia, respectively. By contrast, a higher percentage of OX-ir neurons was found to exhibit Fos-ir without (68%) than with (53%) anesthesia. Thus, a greater percentage of neurons was induced to express Fos-ir when the stressful components of the hypertonic injection were unattenuated by anesthesia, and this difference was entirely due to increased numbers of responding OX neurons. These data indicate that, under these experimental conditions, SON OX neurons respond in larger numbers to the osmotic components of hypertonic saline injections and have a greater responsiveness than do VP neurons to the stressful components.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782874     DOI: 10.1016/0006-8993(95)01466-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.

Authors:  Miguel Lafarga; Maria Teresa Berciano; Emma Pena; Isabel Mayo; Jose G Castaño; Dirk Bohmann; João Pedro Rodrigues; João Paulo Tavanez; Maria Carmo-Fonseca
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

2.  Differential sensitivity of specific neuronal populations of the rat hypothalamus to prolactin action.

Authors:  Tony J Sapsford; Ilona C Kokay; Lovisa Ostberg; Robert S Bridges; David R Grattan
Journal:  J Comp Neurol       Date:  2012-04-01       Impact factor: 3.215

3.  The temporal sequence of gut peptide CNS interactions tracked in vivo by magnetic resonance imaging.

Authors:  Yu-Ting Kuo; James R C Parkinson; Owais B Chaudhri; Amy H Herlihy; Po-Wah So; Waljit S Dhillo; Caroline J Small; Stephen R Bloom; Jimmy D Bell
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

4.  Peripheral osmotic stimulation inhibits the brain's innate immune response to microdialysis of acidic perfusion fluid adjacent to supraoptic nucleus.

Authors:  Joan Y Summy-Long; Sanmei Hu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-16       Impact factor: 3.619

5.  Oxytocin and vasopressin involved in restraint water-immersion stress mediated by oxytocin receptor and vasopressin 1b receptor in rat brain.

Authors:  Dong-Qin Zhao; Hong-Bin Ai
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

6.  Oxytocin-monomeric red fluorescent protein 1 synthesis in the hypothalamus under osmotic challenge and acute hypovolemia in a transgenic rat line.

Authors:  Hiromichi Ueno; Kenya Sanada; Tetsu Miyamoto; Kazuhiko Baba; Kentaro Tanaka; Haruki Nishimura; Kazuaki Nishimura; Satomi Sonoda; Mitsuhiro Yoshimura; Takashi Maruyama; Yasushi Oginosawa; Masaru Araki; Shinjo Sonoda; Tatsushi Onaka; Yutaka Otsuji; Yoichi Ueta
Journal:  Physiol Rep       Date:  2020-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.